Pacira Biosciences
PCRX
#5836
Rank
โ‚ฌ0.92 B
Marketcap
20,61ย โ‚ฌ
Share price
0.04%
Change (1 day)
12.97%
Change (1 year)
Categories

Revenue for Pacira Biosciences (PCRX)

Revenue in 2025 (TTM): โ‚ฌ0.64 Billion

According to Pacira Biosciences 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.61 Billion. In 2024 the company made a revenue of โ‚ฌ0.67 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacira Biosciences from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.64 B-4.59%
2024 โ‚ฌ0.67 B10.32%
2023 โ‚ฌ0.61 B-1.78%
2022 โ‚ฌ0.62 B30%
2021 โ‚ฌ0.47 B36.89%
2020 โ‚ฌ0.34 B-7.06%
2019 โ‚ฌ0.37 B27.48%
2018 โ‚ฌ0.29 B23.42%
2017 โ‚ฌ0.23 B-9.08%
2016 โ‚ฌ0.26 B15.38%
2015 โ‚ฌ0.22 B40.12%
2014 โ‚ฌ0.16 B162.36%
2013 โ‚ฌ61.94 M109.66%
2012 โ‚ฌ29.54 M144.59%
2011 โ‚ฌ12.08 M10.34%
2010 โ‚ฌ10.94 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Recro Pharma
REPH
โ‚ฌ64.72 M-89.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚ฌ86.23 M-85.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
โ‚ฌ6.12 M-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
โ‚ฌ0.13 B-78.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
โ‚ฌ70.16 M-88.60%๐Ÿ‡บ๐Ÿ‡ธ USA